Treatment for Atrial Flutter
Acute Management
- The American Heart Association recommends immediate synchronized cardioversion for patients with hemodynamic instability, such as hypotension, acute heart failure, ongoing chest pain, or altered mental status 1, 2, 3
- Atrial flutter requires lower energy levels for successful cardioversion compared to atrial fibrillation 2, 3
- Beta-blockers, diltiazem, or verapamil are first-line agents for acute rate control in hemodynamically stable patients 1, 4, 3
- Intravenous diltiazem is the preferred calcium channel blocker due to its superior safety and efficacy profile 2, 3
- Esmolol is the preferred intravenous beta-blocker for acute situations due to its rapid onset 2
- Rate control is more difficult in atrial flutter than atrial fibrillation due to less concealed AV nodal conduction 2, 3
- Avoid diltiazem and verapamil in patients with advanced heart failure, heart block, sinus node dysfunction without pacemaker, or pre-excitation 2, 3
- Intravenous amiodarone can be used for rate control in systolic heart failure when beta-blockers are contraindicated or ineffective 1, 4, 3
Anticoagulation
- Antithrombotic therapy in atrial flutter must follow the same protocols as atrial fibrillation, according to the American College of Cardiology 1, 4, 2, 5, 3
- Stroke risk in atrial flutter is significant at 3% annually 2, 3
- Therapeutic anticoagulation for 3 weeks before and 4 weeks after cardioversion is recommended for atrial flutter >48 hours or unknown duration 2, 5
Long-Term Management
- Catheter ablation of the CTI is the definitive treatment and should be strongly considered as first-line therapy, with success rates exceeding 90% and low complication rates 1, 4, 2, 5
- Class I indication for symptomatic atrial flutter or flutter refractory to pharmacological rate control 1, 4
- Reasonable as primary therapy for recurrent symptomatic non-CTI-dependent flutter before antiarrhythmic drug trials 1, 4, 5
- Should be considered in patients undergoing AF ablation who have documented or induced CTI-dependent flutter 1, 4, 5
- Important consideration: 22-50% of patients develop atrial fibrillation within 14-30 months after CTI ablation 2, 5
- Risk factors for post-ablation AF include prior atrial fibrillation, depressed left ventricular function, structural heart disease, and increased left atrial size 2, 5
Special Clinical Scenarios
- CTI ablation is reasonable for patients with CTI-dependent flutter that occurs as a result of flecainide, propafenone, or amiodarone used for atrial fibrillation treatment, according to the American Heart Association 1, 4
- Rapid atrial pacing is particularly effective when temporary atrial wires are already in place, especially in post-cardiac surgery patients 3